AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12950571 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel tip (CT-5)
Number of subjects: 85
Study 12950571 — intervention group
Group type: COMPARATOR
Intervention: Positive controls
Number of subjects: 85
Study 12950571 — intervention group
Group type: COMPARATOR
Intervention: Negative controls
Number of subjects: 85
Study 12950571 — intervention group
Group type: EXPERIMENTAL
Intervention: Three experimental groups (DC, KiS, CT-5)
Number of subjects: 85
Study 11095320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 10 mg
Number of subjects: 603
Study 11095320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 603
Study 11095320 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 603
Study 11095320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study 8870066 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0
Study 8870066 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (d-AMP)
Number of subjects: 0
Study 8870066 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (TRZ)
Number of subjects: 0
Study 1410147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan-deficient amino acid mixture (4.5 hours before morphine administration)
Number of subjects: 0
Study 1410147 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (10 mg intramuscularly)
Number of subjects: 0
Study 1410147 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan-containing mixture (control)
Number of subjects: 0
Study 3904654 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride, 24 to 96 mEq/day
Number of subjects: 16
Study 3904654 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamterene, 50 to 200 mg daily
Number of subjects: 16
Study 3904654 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamterene added to diuretic therapy
Number of subjects: 16
Study 31411147 — intervention group
Group type: EXPERIMENTAL
Intervention: Gout Central app (n=36)
Number of subjects: 72
Study 31411147 — intervention group
Group type: COMPARATOR
Intervention: Dietary app (n=36)
Number of subjects: 72
Study 29602537 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB)
Number of subjects: 91
Study 29602537 — intervention group
Group type: COMPARATOR
Intervention: Measured Resection (MR)
Number of subjects: 91
Study 27383825 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based cognitive training in addition to standard rehabilitation (24 sessions for 8 weeks)
Number of subjects: 20
Study 24297792 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage
Number of subjects: 16
Study 24297792 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein beverage
Number of subjects: 16
Study 24297792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid beverage
Number of subjects: 16
Study 22442101 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 227
Study 22442101 — intervention group
Group type: COMPARATOR
Intervention: First-generation antipsychotics
Number of subjects: 227
Study 21232723 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination-facilitated group (abciximab with half-dose reteplase)
Number of subjects: 637
Study 21232723 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab-facilitated group
Number of subjects: 637
Study 21232723 — intervention group
Group type: COMPARATOR
Intervention: Primary PCI group (no pre-treatment)
Number of subjects: 637
Study 21232723 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI corrected TIMI frame count
Number of subjects: 637
Study 21232723 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI TIMI flow grade 3
Number of subjects: 637
Study 21232723 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI myocardial blush grade 2/3
Number of subjects: 637
Study 18081147 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexandrite laser treatment
Number of subjects: 38
Study 15605283 — intervention group
Group type: EXPERIMENTAL
Intervention: Enuresis alarms (group 1)
Number of subjects: 105
Study 15605283 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desmopressin 400 mug (group 2)
Number of subjects: 105
Study 15605283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (group 3)
Number of subjects: 105
Study 11828811 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting beta 2-agonists
Number of subjects: 0
Study 11265378 — intervention group
Group type: EXPERIMENTAL
Intervention: MPPWs recording in patients with sensorineural hearing loss
Number of subjects: 65
Study 11265378 — intervention group
Group type: EXPERIMENTAL
Intervention: MPPWs recording in patients with retrocochlear hearing loss
Number of subjects: 65
Study 11265378 — intervention group
Group type: COMPARATOR
Intervention: Normal hearing subjects
Number of subjects: 65
Study 9238877 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride dentifrice
Number of subjects: 24
Study 9238877 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice
Number of subjects: 24
Study 9238877 — intervention group
Group type: COMPARATOR
Intervention: Mouthrinsing with 20 ml distilled water
Number of subjects: 24
Study 9238877 — intervention group
Group type: COMPARATOR
Intervention: No mouthrinsing after spitting out
Number of subjects: 24
Study 1534742 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 36
Study 1534742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 36
Study 1534742 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 36
Study 3881160 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy
Number of subjects: 123
Study 3881160 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 123
Study 3881160 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (homogeneous subgroup)
Number of subjects: 123
Study 3881160 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy (homogeneous subgroup)
Number of subjects: 123
Study 3881160 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (central or medial tumors)
Number of subjects: 123
Study 3881160 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy (central or medial tumors)
Number of subjects: 123
Study 3881160 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (lateral tumors)
Number of subjects: 123
Study 3881160 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy (lateral tumors)
Number of subjects: 123
Study 29621979 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment with volar locking plate
Number of subjects: 0
Study 29621979 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment with cast immobilization
Number of subjects: 0
Study 28836987 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training group (HITG), 70%-80% HRR
Number of subjects: 48
Study 28836987 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle-intensity training group (MITG), 50%-70% HRR
Number of subjects: 48
Study 28836987 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-intensity training group (LITG), 40%-50% HRR
Number of subjects: 48
Study 28836987 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 48
Study 25462652 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol only intervention
Number of subjects: 311
Study 25462652 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated intervention
Number of subjects: 311
Study 25462652 — intervention group
Group type: COMPARATOR
Intervention: Referral-only control
Number of subjects: 311
Study 25462652 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood only intervention
Number of subjects: 311
Study 23414176 — intervention group
Group type: EXPERIMENTAL
Intervention: A time limited CBT informed psychological intervention for anxiety in bipolar disorder (AIBD)
Number of subjects: 0
Study 23414176 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 21656179 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose polyethylene glycol (PEG) (2 L/2 L)
Number of subjects: 207
Study 21656179 — intervention group
Group type: COMPARATOR
Intervention: Split-dose aqueous sodium phosphate (NaP) (45 mL/45 mL, 12 h apart)
Number of subjects: 207
Study 18321744 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP/formoterol 100 microg/6 microg
Number of subjects: 18
Study 18321744 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 6 microg
Number of subjects: 18
Study 18321744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16926616 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based anger management group
Number of subjects: 123
Study 16926616 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study 14610480 — intervention group
Group type: EXPERIMENTAL
Intervention: Active therapy (grass pollen immunotherapy)
Number of subjects: 18
Study 14610480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10731916 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-cream 0.05 gm
Number of subjects: 53
Study 10731916 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-cream 0.10 gm
Number of subjects: 53
Study 10731916 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-cream 0.15 gm
Number of subjects: 53
Study 10731916 — intervention group
Group type: EXPERIMENTAL
Intervention: SS-cream 0.20 gm
Number of subjects: 53
Study 10731916 — intervention group
Group type: COMPARATOR
Intervention: Placebo 0.10 gm
Number of subjects: 53
Study 9188946 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (specific immunotherapy)
Number of subjects: 656
Study 9188946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656
Study 12959296 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg tablet
Number of subjects: 12
Study 12959296 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg tablet
Number of subjects: 12
Study 12959296 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg (2 x 250 mg)
Number of subjects: 12
Study 12959296 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg immediately following a standard meal
Number of subjects: 12
Study 12959296 — intervention group
Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 12
Study 3719595 — intervention group
Group type: EXPERIMENTAL
Intervention: intrapleural BCG (5 patients 16 X 10(6), 25 patients 32 X 10(6), and 26 patients 64 X 10(6) culturable particles)
Number of subjects: 99
Study 3719595 — intervention group
Group type: EXPERIMENTAL
Intervention: intrapleural BCG
Number of subjects: 99
Study 3719595 — intervention group
Group type: COMPARATOR
Intervention: historical control population
Number of subjects: 99
Study 29242014 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab combined with multifood oral immunotherapy (n=36)
Number of subjects: 48
Study 29242014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=12)
Number of subjects: 48
Study 29209154 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated supplement
Number of subjects: 21
Study 29209154 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caffeinated supplement
Number of subjects: 21
Study 29209154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 25785955 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR) at 1 level
Number of subjects: 413
Study 25785955 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR) at 2 levels
Number of subjects: 413
Study 25785955 — intervention group
Group type: COMPARATOR
Intervention: Total Disc Replacement (TDR)
Number of subjects: 413
Study 22965657 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 200 U
Number of subjects: 275
Study 22965657 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 300 U
Number of subjects: 275
Study 22965657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 20854954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 329
Study 20854954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin plus GP IIb/IIIa inhibitor
Number of subjects: 329
Study 20854954 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GP IIb/IIIa inhibitor
Number of subjects: 329
Study 18238736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) 50,000 IU once weekly for 12 weeks
Number of subjects: 0
Study 18238736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16359588 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX-A)
Number of subjects: 61
Study 12744911 — intervention group
Group type: EXPERIMENTAL
Intervention: High 5, Low Fat Program (H5LF)
Number of subjects: 738
Study 10776745 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether 6 mg/kg orally six times once every 3 weeks
Number of subjects: 354
Study 10776745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 10776745 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether 6 mg/kg
Number of subjects: 354
Study 8725415 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hetastarch
Number of subjects: 47
Study 8725415 — intervention group
Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 47
Study 11885225 — intervention group
Group type: EXPERIMENTAL
Intervention: Self brushing with acidulated phosphate fluoride (APF) gel (pH 5.6; concentration: 4520 ppm of ion F‐)
Number of subjects: 240
Study 11885225 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 240
Study 3190292 — intervention group
Group type: EXPERIMENTAL
Intervention: New catheter at a new site every 3 days (Group 1)
Number of subjects: 379
Study 3190292 — intervention group
Group type: COMPARATOR
Intervention: Changing catheters over a guide-wire (Group 2)
Number of subjects: 379
Study 31044320 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS stimulation
Number of subjects: 9
Study 31044320 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS stimulation
Number of subjects: 9
Study 28288434 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive education program and switch to a 4mm pen needle
Number of subjects: 75
Study 24947808 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (3 times per week for 3 years)
Number of subjects: 60
Study 24947808 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 60
Study 23763894 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) treatment for major depressive disorder
Number of subjects: 0
Study 23763894 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline EEG power measurements
Number of subjects: 0
Study 21157477 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnuts
Number of subjects: 31
Study 21157477 — intervention group
Group type: EXPERIMENTAL
Intervention: Almonds
Number of subjects: 31
Study 19805710 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral plus nutrition education intervention (Be In CHARGE!)
Number of subjects: 79
Study 19805710 — intervention group
Group type: COMPARATOR
Intervention: Nutrition education intervention alone
Number of subjects: 79
Study 19805710 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 79
Study 17692744 — intervention group
Group type: EXPERIMENTAL
Intervention: BG9928 (3, 15, 75, or 225 mg)
Number of subjects: 50
Study 17692744 — intervention group
Group type: EXPERIMENTAL
Intervention: BG9928 (15, 75, or 225 mg)
Number of subjects: 50
Study 17692744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17692744 — intervention group
Group type: EXPERIMENTAL
Intervention: BG9928 (3 to 225 mg)
Number of subjects: 50
Study 15174010 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPD) 0.4 mg/kg orally
Number of subjects: 0
Study 15174010 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPD) 0.4 mg/kg orally coadministered with levodopa (0.5 mg/kg/hr)
Number of subjects: 0
Study 15174010 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPD) coadministered with levodopa
Number of subjects: 0
Study 15174010 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPD)
Number of subjects: 0
Study 11435843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 43
Study 11435843 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 43
Study 11435843 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 43
Study 9555659 — intervention group
Group type: EXPERIMENTAL
Intervention: IgAN group
Number of subjects: 32
Study 9555659 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 32
Study 9555659 — intervention group
Group type: COMPARATOR
Intervention: Other glomerulonephritis group
Number of subjects: 32
Study 7501342 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick laminaria tents
Number of subjects: 93
Study 7501342 — intervention group
Group type: COMPARATOR
Intervention: 3-mm Hypan tents
Number of subjects: 93
Study 7501342 — intervention group
Group type: COMPARATOR
Intervention: 3-mm magnesium sulfate devices
Number of subjects: 93
Study 2102133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (10 mg i.v.)
Number of subjects: 8
Study 2102133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2102133 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (50 mg/b.i.d.)
Number of subjects: 8
Study 371738 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and antrectomy (TVA)
Number of subjects: 0
Study 371738 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 0
Study 371738 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative patients
Number of subjects: 0
Study 30101386 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-Free Homes: Some Things are Better Outside (minimal intervention)
Number of subjects: 1506
Study 28768250 — intervention group
Group type: EXPERIMENTAL
Intervention: L. gasseri OLL2716 group
Number of subjects: 116
Study 28768250 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 116
Study 25173349 — intervention group
Group type: EXPERIMENTAL
Intervention: EXTRA programme
Number of subjects: 108
Study 25173349 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108
Study 23109617 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Mental Health Triage Tool (FMHT)
Number of subjects: 270
Study 23109617 — intervention group
Group type: COMPARATOR
Intervention: No tool or scale
Number of subjects: 270
Study 21476936 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mm needle
Number of subjects: 130
Study 21476936 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-mm needle
Number of subjects: 130
Study 21476936 — intervention group
Group type: COMPARATOR
Intervention: Both needles
Number of subjects: 130
Study 18264616 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated infant and young child feeding counseling course
Number of subjects: 56
Study 18264616 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 16929706 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive/dependent group
Number of subjects: 106
Study 16929706 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive/nondependent group
Number of subjects: 106
Study 16929706 — intervention group
Group type: COMPARATOR
Intervention: Normotensive/dependent group
Number of subjects: 106
Study 16929706 — intervention group
Group type: COMPARATOR
Intervention: Normotensive/nondependent group
Number of subjects: 106
Study 12713981 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic RT (46 Gy)
Number of subjects: 714
Study 12713981 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 714
Study 11009049 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp30 (0.2 U x kg(-1) bodyweight)
Number of subjects: 24
Study 11009049 — intervention group
Group type: COMPARATOR
Intervention: BHI30 (0.2 U x kg(-1) bodyweight)
Number of subjects: 24
Study 1661645 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (0.07 units/kg at night)
Number of subjects: 24
Study 1661645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7041324 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole 80 mg daily for two months
Number of subjects: 10
Study 7041324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30968066 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% w/w calcium sodium phosphosilicate (CSPS) dentifrice (test)
Number of subjects: 151
Study 30968066 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% w/w arginine dentifrice (comparator)
Number of subjects: 151
Study 30968066 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 151
Study 29623143 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (15 μg·kg‐1·ml‐1) with flurbiprofen
Number of subjects: 158
Study 29623143 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil with flurbiprofen
Number of subjects: 158
Study 26887663 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 173
Study 26887663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 25149899 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle aponeurotomy combined with triamcinolone injections
Number of subjects: 44
Study 25149899 — intervention group
Group type: COMPARATOR
Intervention: Needle aponeurotomy alone
Number of subjects: 44
Study 22423956 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) insufflation under general anesthesia (Group GC)
Number of subjects: 57
Study 22423956 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless technique under general anesthesia (Group GG)
Number of subjects: 57